Testosterone Enanthate is usually administered in women to cure Metastatic Mammary Cancer. The name of the injection is DELATESTRYL® (Testosterone Enanthate Injection, USP). The medication is used on the women that are one to five years postmenopausal.
The women that have ablation of the ovaries, are treated with Testosterone Enanthate adrenalectomy, hypophysectomy, and/or antiestrogen therapy are the other methods of counteracting estrogen activity. This method is also applicable the premenopausal women in case they have breast cancer. These women have reportedly benefited from oophorectomy and are considered to have a hormone-responsive tumor. However, the dosages are determined only under the prescription of an oncologist or an expert in this field.
Dosage and duration of the therapy with DELATESTRYL® (Testosterone Enanthate Injection, USP) will be based on age, sex, diagnosis, patient’s response to the treatment and the emergence of any adverse effects. One also needs to make sure that the injections of DELATESTRYL are well tolerated when the injections are given. The substance needs to be slowly injected deeply into the gluteal muscle by taking all the precautions prescribed for intramuscular administration such as the avoidance of intravascular injection.
It is advisable not to administer more than 400mg per month on a patient in general cases because it has prolonged action. Word of caution: avoid using a wet syringe or wet needle because it may cause the solution to become cloudy but then it doesn’t affect the quality of the substance. Prior to the administration, parenteral drug products should be scrutinized visually for particulate matter and discoloration. DELATESTRYL is clear to look at but sometimes it appears like pale yellow.